SAN

102.7

-0.06%↓

EI

267.8

+0.26%↑

SHL.DE

50.08

-0.4%↓

ARGX

545.2

+0.48%↑

PHIA

23.66

+1.5%↑

SAN

102.7

-0.06%↓

EI

267.8

+0.26%↑

SHL.DE

50.08

-0.4%↓

ARGX

545.2

+0.48%↑

PHIA

23.66

+1.5%↑

SAN

102.7

-0.06%↓

EI

267.8

+0.26%↑

SHL.DE

50.08

-0.4%↓

ARGX

545.2

+0.48%↑

PHIA

23.66

+1.5%↑

SAN

102.7

-0.06%↓

EI

267.8

+0.26%↑

SHL.DE

50.08

-0.4%↓

ARGX

545.2

+0.48%↑

PHIA

23.66

+1.5%↑

SAN

102.7

-0.06%↓

EI

267.8

+0.26%↑

SHL.DE

50.08

-0.4%↓

ARGX

545.2

+0.48%↑

PHIA

23.66

+1.5%↑

Search

Fresenius SE & Co KGaA

Open

BrancheGesundheitswesen

39.57 0.56

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

38.92

Max

39.73

Schlüsselkennzahlen

By Trading Economics

Einkommen

-55M

264M

Verkäufe

264M

5.6B

KGV

Branchendurchschnitt

48.732

73.239

Gewinnspanne

4.689

EBITDA

-33M

724M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+13.47% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

1.6B

23B

Vorheriger Eröffnungskurs

39.01

Vorheriger Schlusskurs

39.57

Nachrichtenstimmung

By Acuity

33%

67%

89 / 386 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Fresenius SE & Co KGaA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

26. Feb. 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

5. Juni 2024, 12:18 UTC

Market Talk

Fresenius Helios Guidance Lift Should Drive Consensus Upgrades -- Market Talk

Peer-Vergleich

Kursveränderung

Fresenius SE & Co KGaA Prognose

Kursziel

By TipRanks

13.47% Vorteil

12-Monats-Prognose

Durchschnitt 45.4 EUR  13.47%

Hoch 48 EUR

Tief 42 EUR

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Fresenius SE & Co KGaA – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

12 ratings

11

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

39.92 / 40.23Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

89 / 386 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.